RadNet (RDNT) Competitors $55.48 -2.02 (-3.51%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$55.50 +0.02 (+0.03%) As of 07/11/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RDNT vs. FMS, HIMS, GH, OPCH, BTSG, SHC, SGRY, PRVA, CON, and WGSShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry. RadNet vs. Its Competitors Fresenius Medical Care AG & Co. KGaA Hims & Hers Health Guardant Health Option Care Health BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent GeneDx RadNet (NASDAQ:RDNT) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk. Which has stronger valuation & earnings, RDNT or FMS? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.83B2.28$2.79M-$0.43-129.02Fresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.1224.14 Do analysts rate RDNT or FMS? RadNet currently has a consensus target price of $69.60, indicating a potential upside of 25.45%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $27.80, indicating a potential upside of 2.81%. Given RadNet's stronger consensus rating and higher probable upside, equities research analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 3 Strong Buy rating(s) 3.50Fresenius Medical Care AG & Co. KGaA 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders believe in RDNT or FMS? 77.9% of RadNet shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to RDNT or FMS? In the previous week, RadNet had 8 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 8 mentions for RadNet and 0 mentions for Fresenius Medical Care AG & Co. KGaA. RadNet's average media sentiment score of 1.24 beat Fresenius Medical Care AG & Co. KGaA's score of 0.51 indicating that RadNet is being referred to more favorably in the media. Company Overall Sentiment RadNet Positive Fresenius Medical Care AG & Co. KGaA Positive Which has more volatility & risk, RDNT or FMS? RadNet has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Is RDNT or FMS more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to RadNet's net margin of -1.73%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-1.73% 1.41% 0.48% Fresenius Medical Care AG & Co. KGaA 3.18%6.25%2.88% SummaryRadNet beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks. Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.16B$4.95B$5.56B$9.11BDividend YieldN/A1.33%5.06%4.01%P/E Ratio-129.0235.5828.2620.26Price / Sales2.2890.49437.10166.10Price / Cash15.9322.9337.1257.67Price / Book3.624.328.045.49Net Income$2.79M$189.47M$3.19B$250.45M7 Day Performance-1.21%-3.28%3.62%4.79%1 Month Performance0.13%-5.38%5.98%9.59%1 Year Performance-9.66%-1.25%29.39%16.41% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet4.2683 of 5 stars$55.48-3.5%$69.60+25.5%-9.7%$4.16B$1.83B-129.0211,021News CoveragePositive NewsAnalyst ForecastFMSFresenius Medical Care AG & Co. KGaA3.4224 of 5 stars$28.60+1.4%$27.80-2.8%+35.9%$16.78B$19.49B25.541,384HIMSHims & Hers Health2.0826 of 5 stars$49.94+1.1%$39.58-20.7%+120.7%$11.18B$1.48B72.381,637Trending NewsAnalyst DowngradeInsider TradeGHGuardant Health4.116 of 5 stars$52.04+2.3%$53.76+3.3%+61.7%$6.45B$739.02M-15.352,021OPCHOption Care Health4.5474 of 5 stars$32.48+0.7%$35.50+9.3%+1.7%$5.32B$5.00B26.198,088News CoveragePositive NewsAnalyst ForecastBTSGBrightSpring Health Services1.7427 of 5 stars$23.59+0.2%$24.90+5.6%+83.6%$4.15B$11.27B84.2535,000SHCSotera Health3.1603 of 5 stars$11.12-1.8%$16.00+43.9%-4.5%$3.16B$1.10B139.023,000SGRYSurgery Partners2.4768 of 5 stars$22.23+1.3%$33.56+50.9%-18.0%$2.85B$3.17B-14.5315,000PRVAPrivia Health Group4.5032 of 5 stars$23.00+4.5%$27.77+20.7%+14.2%$2.80B$1.74B191.681,140News CoverageAnalyst ForecastHigh Trading VolumeCONConcentra Group Holdings Parent2.9071 of 5 stars$20.59-2.6%$28.50+38.4%N/A$2.64B$1.90B15.3711,250News CoverageWGSGeneDx3.8452 of 5 stars$92.31+1.3%$90.13-2.4%+151.7%$2.63B$305.45M-65.471,200Trending NewsAnalyst ForecastInsider Trade Related Companies and Tools Related Companies Fresenius Medical Care AG & Co. KGaA Alternatives Hims & Hers Health Alternatives Guardant Health Alternatives Option Care Health Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives GeneDx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDNT) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
